• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
8 results

Composition and Method for Treating Neurological Disease

Docket 15/898,143, U.S. Patent Application (Feb. 15, 2018)
Art Group1627
Case TypeUtility - 514/662000
Class514
Patent10213393
Orange Book Patent10213393
Inventor Glenn A. MEYER
Inventor Joaquina FAOUR
Inventor Ana Cristina PASTINI
...
cite Cite Docket
Analyze

Miscellaneous Internal Document

Document Composition and Method for Treating Neurological Disease, 15/898,143, No. 1-4-US-158981430SP1 (U.S. Pat. App. May. 15, 2020)
CHANGE OF ENTITY STATUS PURSUANT TO 37 C.F.R. §1.27 (c) (1) Commissioner for Patents Mail Stop M Correspondence PO.
Box 1450 Alexandria, VA 22313-1450 Sir: By way of this communication, Applicant/Assignee/Patentee hereby asserts that the attached Schedule A patents are entitled to Small Entity status.
Address of Signatory or Patentee" Osmotica Kereskedelmi es Szolgaltato KFl' Berlini U.
47-49 Budapest, Hungary H-1045 Respectfully submitted by: Wfl KM Authorised Signatory* Christopher Klein Print Name" _ General Counsel Title’ (Owner.
Liberation House Castle Street, St Helier Jersey JE 1 lBL Tel +44 (0) 1534 888711 Fax +44 (0) 1534 888747 enquiries©cpagloba| .com www.cpaglobal .com To:
cite Cite Document
Analyze

Assertion of entitlement to small entity status via PAIR

Document Composition and Method for Treating Neurological Disease, 15/898,143, No. 1-1-US-158981430RP1 (U.S. Pat. App. May. 11, 2020)
United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS PO.
111876 Acknowledgement of Change to Small Entity Status The entity status change request below filed through Private PAIR on 05/11/2020 has been accepted.
Change of Entity Status: loss of entitlement to micro entity status.
X Applicant asserting small entity status.
NOTE: If the application was previously under micro entity status, checking this box will be taken to be a notification of This portion must be completed by the signatory or signatories making the entity status change in accordance with 37 CFR 1.4(d)(4).
cite Cite Document
Analyze

Request for Certificate of Correction

Document Composition and Method for Treating Neurological Disease, 15/898,143, No. 8-5-US-158981430PP1 (U.S. Pat. App. Mar. 29, 2019)
DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number Also Form PTO-1050
In Col. 27, Lines 66-67, delete “thilthixene, trifluoroperazine,” and insert - - thiothixene, MAILING ADDRESS OF SENDER (Please do not use customer number below): Sterne, Kessler, Goldstein & Fox P.L.L.C. 1100 New York Avenue, NW Atty.
DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number Also Form PTO-1050
DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number Also Form PTO-1050
DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number Also Form PTO-1050
cite Cite Document
Analyze

1-7-US-158981430PP1

Document Composition and Method for Treating Neurological Disease, 15/898,143, No. 1-7-US-158981430PP1 (U.S. Pat. App. Mar. 29, 2019)

cite Cite Document
Analyze

1-3-US-158981430QP1

Document Composition and Method for Treating Neurological Disease, 15/898,143, No. 1-3-US-158981430QP1 (U.S. Pat. App. May. 7, 2019)

cite Cite Document
Analyze

Fee Worksheet (SB06)

Document Composition and Method for Treating Neurological Disease, 15/898,143, No. 13-2-US-158981430PP1 (U.S. Pat. App. Mar. 29, 2019)
Log in to see more
cite Cite Document
Analyze

EFS Acknowledgment Receipt

Document Composition and Method for Treating Neurological Disease, 15/898,143, No. 15-2-US-158981430PP1 (U.S. Pat. App. Mar. 29, 2019)
Log in to see more
cite Cite Document
Analyze

Can’t find a case you think should be here?

Use our supplemental search tool to find dockets that you may not see here. Information on Fees

Start a Supplemental Search